These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10657399)

  • 1. Hemolyzed specimens: a reason for rejection or a clinical challenge?
    Carraro P; Servidio G; Plebani M
    Clin Chem; 2000 Feb; 46(2):306-7. PubMed ID: 10657399
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimated National Volume of Laboratory Results Affected by Hemolyzed Specimens From Emergency Departments.
    Phelan MP; Reineks EZ; Schold JD; Kovach A; Venkatesh AK
    Arch Pathol Lab Med; 2016 Jul; 140(7):621. PubMed ID: 27362565
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories.
    Lippi G; Plebani M; Di Somma S; Cervellin G
    Crit Rev Clin Lab Sci; 2011; 48(3):143-53. PubMed ID: 21875312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Rejection: Analysis of Specimen Acceptability and Rejection, and Framework for Identifying Interventions in a Single Tertiary Healthcare Facility.
    Rooper L; Carter J; Hargrove J; Hoffmann S; Riedel S
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27629723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quality improvement cycle: hemolyzed specimens in the emergency department.
    Pretlow L; Gandy T; Leibach EK; Russell B; Kraj B
    Clin Lab Sci; 2008; 21(4):219-24. PubMed ID: 19174982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to managing hemolyzed specimens.
    Pretlow L; Johnson S; Russell B; Evans B
    Clin Lab Sci; 2013; 26(3):153-7. PubMed ID: 23967544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practices for Identifying and Rejecting Hemolyzed Specimens Are Highly Variable in Clinical Laboratories.
    Howanitz PJ; Lehman CM; Jones BA; Meier FA; Horowitz GL
    Arch Pathol Lab Med; 2015 Aug; 139(8):1014-9. PubMed ID: 26230594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suitability of hemolyzed specimens for compatibility testing using automated technology.
    Laga A; Cheves T; Maroto S; Coutts M; Sweeney J
    Transfusion; 2008 Aug; 48(8):1713-20. PubMed ID: 18482191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of specimen hemolysis on coagulation test results.
    Laga AC; Cheves TA; Sweeney JD
    Am J Clin Pathol; 2006 Nov; 126(5):748-55. PubMed ID: 17050072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement.
    Lippi G; Salvagno GL; Favaloro EJ; Guidi GC
    Clin Chem Lab Med; 2009; 47(5):616-8. PubMed ID: 19317651
    [No Abstract]   [Full Text] [Related]  

  • 11. Practices for Identifying and Rejecting Hemolyzed Specimens in Europe.
    Lippi G
    Arch Pathol Lab Med; 2016 Jul; 140(7):622. PubMed ID: 27362566
    [No Abstract]   [Full Text] [Related]  

  • 12. Using hemolyzed specimens.
    Alter D; Sykes E
    Am J Clin Pathol; 2000 Nov; 114(5):820-1. PubMed ID: 11068559
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemistry specimen acceptability: a College of American Pathologists Q-Probes study of 453 laboratories.
    Jones BA; Calam RR; Howanitz PJ
    Arch Pathol Lab Med; 1997 Jan; 121(1):19-26. PubMed ID: 9111088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis interference in measuring fish plasma biochemical indicators.
    Mirghaed AT; Ghelichpour M; Hoseini SM; Amini K
    Fish Physiol Biochem; 2017 Aug; 43(4):1143-1151. PubMed ID: 28293862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hemolysis during sample collection: how different is drug concentration in hemolyzed plasma from that of normal plasma?
    Tan A; Gagné S; Lévesque IA; Lachance S; Boudreau N; Lévesque A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():79-84. PubMed ID: 22748717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of laboratory sample rejections in the pre-analytical stage at an oncology center.
    Bhat V; Tiwari M; Chavan P; Kelkar R
    Clin Chim Acta; 2012 Aug; 413(15-16):1203-6. PubMed ID: 22507083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolyzed Specimens: Major Challenge for Identifying and Rejecting Specimens in Clinical Laboratories.
    Wan Azman WN; Omar J; Koon TS; Tuan Ismail TS
    Oman Med J; 2019 Mar; 34(2):94-98. PubMed ID: 30918601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Pneumatic Tube System Transport Contribute to Hemolysis in ED Blood Samples?
    Phelan MP; Reineks EZ; Hustey FM; Berriochoa JP; Podolsky SR; Meldon S; Schold JD; Chamberlin J; Procop GW
    West J Emerg Med; 2016 Sep; 17(5):557-60. PubMed ID: 27625719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference studies: focus on blood cell lysates preparation and testing.
    Lippi G
    Clin Lab; 2012; 58(3-4):351-5. PubMed ID: 22582513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid emulsion solution: A novel cause of hemolysis in serum and plasma blood samples.
    Jaben EA; Koch CD; Karon BS
    Clin Biochem; 2011 Feb; 44(2-3):254-6. PubMed ID: 21070759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.